Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 32

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 4
Chunk 32
---
,227)Net investment (loss) income(18)463 231 20 696 Total revenues148,229 39,821 627 (7,205)181,472 Net investment results from certain equity method investments— (238)— — (238)Special item related to impairment of dividend receivable182 — — — 182 Adjusted revenues$148,411 $39,583 $627 $(7,205)$181,416 Pharmacy and other service costs140,458 — Medical costs— 27,886 Selling, general and administrative expenses2,825 7,986 Other segment items (1)Interest (expense) and other(2)7 Less: Income attributable to noncontrolling interests271 — Pre-tax adjusted income (loss) from operations4,855 3,718 (4)(1,269)7,300 Income (loss) before income taxes$1,494 $3,221 $(9)$(1,446)$3,260 Pre-tax adjustments to reconcile to adjusted income from operations(Income) attributable to noncontrolling interests(271)— — — (271)Net investment losses (2)2,203 359 5 — 2,567 Amortization of acquired intangible assets1,247 32 — — 1,279 Special itemsIntegration and transaction-related costs— — — 177 177 Loss on sale of businesses— 106 — — 106 Impairment of dividend receivable 182 — — — 182 Pre-tax adjusted income (loss) from operations$4,855 $3,718 $(4)$(1,269)$7,300 Other segment informationDepreciation and amortization$1,764 $334 $7 $24 $2,129 (1)Other segment items represent the difference between segment adjusted revenues less significant segment expenses and pre-tax adjusted income (loss) from operations, and they do not represent significant segment items relative to the CODM's review and oversight.(2)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolid